(Z)-7-[(1S,5E)-5-[(E)-oct-2-enylidene]-4-oxo-1-cyclopent-2-enyl]hept-5-enoic acid,87-57-0 Products Supply

Name: (Z)-7-[(1S,5E)-5-[(E)-oct-2-enylidene]-4-oxo-1-cyclopent-2-enyl]hept-5-enoic acid
CAS NO.: 87-57-0
Synonyms:
15d-PGJ2;15-Deoxy-PGJ2;15-deoxy-delta-12,14-PGJ2;15-Deoxy-delta-12,14-prostaglandin J2;15-Deoxy-delta12,14-PGJ2;15-Deoxy-delta12,14-prostaglandin;15-Deoxy-delta-12, 14 PGJ-2;15-Deoxy-delta 12, 14-Prostaglandin J2;87893-55-8;AC1NSK7W;delta12,14-PGJ2;Spectrum5_001971;delta12,14-PGJ 2;C14717;15-deoxy-prostaglandin J2;BSPBio_001361;BML2-B05;CHEMBL482477;HMDB05079;15-Deoxy.delta.12,14PGJ2;CHEBI:607727;15-Deoxy-d-12,14-PGJ2;HMS1361E03;HMS1791E03;HMS1989E03;15-Deoxy .delta.12,14PGJ2;LMFA03010021;15-Deoxy-DELTA(12,14)-PGJ2;IDI1_033831;11-oxo-5Z,9,12,14-prostatetraenoate;15-deoxy-delta12,14-prostaglandin J2;NCGC00161304-01;NCGC00161304-02;NCGC00161304-03;NCGC00161304-04;NCGC00161304-05;Prostaglandin J2, 15-Deoxy-Delta12,14;11-oxo-5Z,9,12,14-prostatetraenoic acid;FT-0080119;11-oxo-5Z,9,12E,14E-prostatetraenoic acid;BRD-K05396879-001-02-6;(5Z,12E,14E) 11-oxo Prosta-5,9,12,14-tetraen-1-oate;(5Z,12E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid;(5Z,12E,14E) 11-oxo Prosta-5,9,12,14-tetraen-1-oic acid;(5Z,12E,14E)-11-oxo-prosta-5,9,12,14-tetraen-1-oic acid;Prosta-5,9,12,14-tetraen-1-oic acid, 11-oxo (5Z,12E,14E);prosta-5,9,12,14-tetraen-1-oic acid, 11-oxo-, (5Z,12E,14E)-;Prosta-5,9,12,14-tetraen-1-oic acid, 11-oxo-, (5Z,12E,14E)- (9CI);(5Z,12E,14E)-11-oxo-prosta-5,9,12,14-tetraen-1-oate;delta-12,14-15-deoxy-PGJ2;(Z)-7-[(1S,5E)-5-[(E)-oct-2-enylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid;87-57-0
Molecular Structure:
Molecular Formula: C₂₀H₂₈O₃

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: (Z)-7-[(1S,5E)-5-[(E)-oct-2-en; (Z)-7-[(1S,2R,3R)-3-hydroxy-5-; (Z)-7-[(1S,2R,3R,5S)-3,5-dihyd; 7-(2-oct-2-enylidene-3-oxocycl; (Z)-7-[(1R,2R,3R,5S)-5-ACETOXY; (Z)-7-{(1R,2R,3R,5S)-3-(tert-B; (Z)-7-[(1R,2S)-2-[(E,3R)-3-hy; (E)-7-[(1R,2S,3R)-3-hydroxy-2-; (Z)-7-[(1R,2S,3R,5S)-2-[(E)-4-; 7-[(1S,2R)-2-(4-cyclohexyl-3-h; (Z)-7-((1S,2R,3aR,4R,7R,7aS,8S; (Z)-7-[(1R,2R,3R,5S)-3,5-DIHYD; (Z)-7-[(1R,2R,3R)-2-[(E,3S,7R); (Z)-7-((1S,2S,3R,E)-3-((tert-b; (Z)-7-((1S,2S,3R,5S)-3-((tert-; (5E)-5-[(E)-3-(2-nitrophenyl)p; (Z)-7-((1S,2S,3R,5S)-3-((tert-; 7-[3-(3-hydroxyoct-1-enyl)-4,6; methyl (S,E)-7-{(1S,2R,3R,5S)-; methyl (E)-7-[(1R,2S)-2-[(E)-4; (E)-7-[(2S,3R)-3-[(E,3S)-3-hyd; (Z)-7-[(1S,2R,3R,5S)-3,5-dihyd; [4-(dimethyl-t-butylsilyloxy)-; (5E)-7-{3-[(2-hydroxydecyl)ami; (5E)-7-[3-({3-[(4-ethylphenyl); (5-OXO-2-PHENYL-CYCLOPENT-1-EN; 7-((1S,4R,5R)-4-((tert-butyldi; 7-(2-oct-2-enylidene-5-oxocycl; (5E)-7-{3,5-dihydroxy-2-[(1E)-; (5Z)-7-((1R,2R,3R)-3-((tert-bu;